3//SEC Filing
Ipsen, S.A. 3
Accession 0001104659-17-060880
CIK 0001649904other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:46 PM ET
Size
7.3 KB
Accession
0001104659-17-060880
Insider Transaction Report
Form 3
Ipsen, S.A.
10% Owner
Holdings
- 599,330(indirect: The owner of record of the securities is Sutrepa SAS. Sutrepa SAS is controlled by Ipsen SA)
Common Stock
- (indirect: The owner of record of the securities is Sutrepa SAS. Sutrepa SAS is controlled by Ipsen SA)
Series A-1 Junior Convertible Preferred Stock
→ Common stock (45,831 underlying) - (indirect: The owner of record of the securities is Sutrepa SAS. Sutrepa SAS is controlled by Ipsen SA)
Series A Convertible Preferred Stock
→ Common Stock (167,938 underlying)
Footnotes (2)
- [F1]At any time at the holder's election or upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's series A-1 junior convertible preferred stock (the "Series A-1 Junior Preferred") is convertible into shares of the Issuer's common stock on a 9.17-for-one basis without payment or consideration. The Series A-1 Junior Preferred has no expiration date.
- [F2]At any time at the holder's election or upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's series A convertible preferred stock (the "Series A Preferred") is convertible into shares of the Issuer's common stock on a 9.17-for-one basis without payment or consideration. The Series A Preferred has no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
IncorporatedFrance
Related Parties
1- filerCIK 0001370483
Filing Metadata
- Form type
- 3
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:46 PM ET
- Size
- 7.3 KB